Envoy Medical, Inc.COCH
Price (close)
$0.71
Market cap
$55.2M
P/E
—
Revenue (TTM)
$207,000
Net income
-$23.4M
Dividend yield
—
1-year total return
-16.0%
Net margin
-11304.8%
Revenue growth
-6.8%
Debt / equity
—
What Envoy Medical, Inc. does.
or “our” refer to Envoy Medical, Inc. following the Business Combination, other than certain historical information which
company focused on providing innovative medical technologies across the hearing loss spectrum. Our technologies are designed to shift
the paradigm within the hearing industry and bring both providers and patients the hearing devices they desire. We are dedicated to pushing
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $237,000 | $316,000 | $225,000 | $241,000 |
| Net income | — | -$251,633 | -$15.9M | -$29.9M | -$20.8M | -$23.8M |
| Free cash flow | — | — | -$9.0M | -$17.2M | -$18.9M | -$18.4M |
More on COCH.
- Envoy Medical, Inc. summary
- Envoy Medical, Inc. financial statements
- Envoy Medical, Inc. key metrics
- Envoy Medical, Inc. health scores and style box
- Envoy Medical, Inc. earnings
- Envoy Medical, Inc. dividends
- Envoy Medical, Inc. valuation
- Envoy Medical, Inc. ownership and insiders
- Envoy Medical, Inc. peers
Figures from Envoy Medical, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.